China Diagnostic Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The China Diagnostic Imaging Market is segmented By Modality (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, Mammography), By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, and Other Applications), and By End-User (Hospitals, Diagnostic Centers, and Other End-Users). The report offers the value (in USD million) for the above segments.

China Diagnostic Imaging Industry Overview

Image 1_China Diagnostic Imaging Equipment Market
Study Period: 2018 - 2028
CAGR: 11.3 %

Major Players


*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

China Diagnostic Imaging Market Analysis

The China diagnostic imaging market is expected to register a CAGR of 11.3% during the forecast period(2022 - 2027). The market is expected to show healthy growth owing to the growing prevalence of chronic diseases, the growing geriatric population, and the increased adoption of advanced technologies in medical imaging.

With the rising geriatric population, the country is found witnessing a significant increase in the number of patients suffering from chronic diseases.

According to an article titled “China’s Ageing Population: The Present Situation and Prospects” published in April 2020, both quantitatively and structurally, the population of China is aging quickly. About 6.2 million persons over the age of 60 are added to the population every year. According to this definition of the elderly, 280 million people will be considered elderly in China by 2025. As the aged population is more prone to chronic diseases such as cardiovascular, cancer, respiratory and neurological diseases which will boost the market during the forecast period.

Hence it is seen that most of the elderly population are utilizing diagnostic imaging techniques, as compared to the younger people. Therefore, the growing geriatric population is expected to augment the demand for the diagnostic imaging market.

There are also many advancements made in the field that are accelerating the speed to capture high-quality diagnostic images, capturing images at the right place and right time, to help provide better patient care at less cost, thus automating the workflow, and acting as one of the major drivers of the market.

China Diagnostic Imaging Industry Segments

As per the scope of the report, diagnostic imaging captures images of the internal structure of the human body using electromagnetic radiation for an accurate diagnosis. There are various types of medical imaging, the most common ones being CT scanners, MRI systems, etc. The China diagnostic imaging market is segmented by modality, application, end-user and geography. The report offers the value (in USD million) for the above segments.

By Modality
Low and mid field MRI systems (less than 1.5 T)
High field MRI systems (1.5-3 T)
Very High, and Ultra High Field MRI Systems (3T and more)
Computed Tomography
Low End Scanners (~16-Slice)
Mid Range Scanners (~64-Slice)
High End Scanners (128-Slice and More)
2D Ultrasound
3D Ultrasound
Analog Systems
Digital Systems
Nuclear Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
By Application
Other Applications
By End-User
Diagnostic Centers
Other End-Users

Report scope can be customized per your requirements. Click here.

China Diagnostic Imaging Market Trends

This section covers the major market trends shaping the China Diagnostic Imaging Market according to our research experts:

Oncology Segment is Expected to Hold a Major Market Share in the China Diagnostic Imaging Market

Cancer incidence and mortality have been increasing in China for a long time, thus making it the leading cause of death in this country. As per an article titled “Comparison of cancer incidence and mortality between China and the United States” published in December 2021, in 2020, there are 4.6 million new cases in China and the Age-standardized mortality rate (ASMR) of cancer in China is 129.4 per 100,000.

Similarly, according to an article titled “Cancer statistics in China and United States, 2022: profiles, trends, and determinants” published in February 2022, it is expected that approximately 4,820,000 people are expected to have newly diagnosed with cancer, and 3,210,000 people dying from cancer in China in 2022.

Furthermore, China is attempting to address its steadily rising cancer burden. However, it faces numerous new obstacles to cancer prevention due to the rising aging of the population and the cumulative impact of risk factor exposure. Cancer profiles, trends, and factors in China and the USA could be compared to help China with its cancer preventive initiatives and policymaking.

The rising burden is also attributable to population growth and aging and socio-demographic changes. Hence the rising prevalence of various types of cancer in China and the increasing need for cost-effective diagnosis using advanced cancer imaging techniques are expected to drive the market.


China Diagnostic Imaging Market Competitor Analysis

The China Diagnostic Imaging Market is moderately consolidated competitive. The market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Canon Medical Systems Corporation, Carestream Health Inc., Fujifilm Holding, GE Healthcare (GE Company), Hitachi Medical Systems, and Hologic Corporation.

China Diagnostic Imaging Market Top Players

  1. Carestream Health Inc.

  2. Fujifilm Holding

  3. GE Healthcare (GE Company)

  4. Hitachi Medical Systems

  5. Hologic Corporation

*Disclaimer: Major Players sorted in no particular order

China Diagnostic Imaging Market.png

China Diagnostic Imaging Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in the Prevalence of Chronic Diseases

      2. 4.2.2 Growing Geriatric Population

      3. 4.2.3 Increased Adoption of Advanced Technologies in Medical Imaging

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs Associated With the Devices

      2. 4.3.2 Side Effects of Diagnostic Imaging Procedures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Modality

      1. 5.1.1 MRI

        1. Low and mid field MRI systems (less than 1.5 T)

        2. High field MRI systems (1.5-3 T)

        3. Very High, and Ultra High Field MRI Systems (3T and more)

      2. 5.1.2 Computed Tomography

        1. Low End Scanners (~16-Slice)

        2. Mid Range Scanners (~64-Slice)

        3. High End Scanners (128-Slice and More)

      3. 5.1.3 Ultrasound

        1. 2D Ultrasound

        2. 3D Ultrasound

        3. Others

      4. 5.1.4 X-Ray

        1. Analog Systems

        2. Digital Systems

      5. 5.1.5 Nuclear Imaging

        1. Positron Emission Tomography (PET)

        2. Single Photon Emission Computed Tomography (SPECT)

      6. 5.1.6 Fluoroscopy

      7. 5.1.7 Mammography

    2. 5.2 By Application

      1. 5.2.1 Cardiology

      2. 5.2.2 Oncology

      3. 5.2.3 Neurology

      4. 5.2.4 Orthopedics

      5. 5.2.5 Gastroenterology

      6. 5.2.6 Gynecology

      7. 5.2.7 Other Applications

    3. 5.3 By End-User

      1. 5.3.1 Hospitals

      2. 5.3.2 Diagnostic Centers

      3. 5.3.3 Other End-Users


    1. 6.1 Company Profiles

      1. 6.1.1 Canon Medical Systems Corporation

      2. 6.1.2 Carestream Health Inc.

      3. 6.1.3 Fujifilm Holding

      4. 6.1.4 GE Healthcare (GE Company)

      5. 6.1.5 Hitachi Medical Systems

      6. 6.1.6 Hologic Corporation

      7. 6.1.7 Philips Healthcare

      8. 6.1.8 Shimadzu Medical

      9. 6.1.9 Siemens Healthcare

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

China Diagnostic Imaging Market Research FAQs

The China Diagnostic Imaging Market is studied from 2018 - 2028.

The China Diagnostic Imaging Market is growing at a CAGR of 11.3% over the next 5 years.

Carestream Health Inc., Fujifilm Holding, GE Healthcare (GE Company), Hitachi Medical Systems, Hologic Corporation are the major companies operating in China Diagnostic Imaging Market.

China Diagnostic Imaging Industry Reports

In-depth industry statistics and market share insights of the China Diagnostic Imaging sector for 2020, 2021, and 2022. The China Diagnostic Imaging research report provides a comprehensive outlook of the market size and an industry growth forecast for 2023 to 2028. Available to download is a free sample file of the China Diagnostic Imaging report PDF.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!